Free Trial
NASDAQ:ZIMV

ZimVie Q2 2025 Earnings Report

ZimVie logo
$18.76 -0.03 (-0.16%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$18.76 0.00 (0.00%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie EPS Results

Actual EPS
$0.26
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ZimVie Revenue Results

Actual Revenue
$116.66 million
Expected Revenue
$112.60 million
Beat/Miss
Beat by +$4.06 million
YoY Revenue Growth
N/A

ZimVie Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, July 30, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

ZimVie's Q3 2025 earnings is scheduled for Thursday, August 7, 2025

ZimVie Earnings Headlines

ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
This rock I’m holding could be worth trillions
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.
See More ZimVie Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ZimVie? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZimVie and other key companies, straight to your email.

About ZimVie

ZimVie (NASDAQ:ZIMV), together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

View ZimVie Profile

More Earnings Resources from MarketBeat